Alnylam Pharmaceuticals (ALNY) Price to Sales (2009 - 2026)
Alnylam Pharmaceuticals' Price to Sales was 6.58 in Q3 2026, down 65.9% from 19.28 a year earlier and down 21.5% from the prior quarter.
Powered by 
Analysis
Alnylam Pharmaceuticals (ALNY) Price to Sales (2009 - 2026) Analysis & Trends
For FY2025, Price to Sales at Alnylam Pharmaceuticals came in at 14.17, up 4.7% from FY2024.
- In earlier years, Price to Sales was 13.53 in FY2024 (+2.8%), 13.17 in FY2023 (-53.6%), 28.39 in FY2022 (+17.6%) and 24.14 in FY2021 (-21.4%).
- The Q3 2026 figure marks the lowest quarterly Price to Sales since Q4 2011.
- Compared with a year earlier, Price to Sales was higher in four of the last six quarters, with an average decline of 11.2%.
- The best year-over-year quarter for Price to Sales over five years was Q3 2024 (growth of 31.2%); the worst was Q3 2026 (a decline of 65.9%).
- Per Business Quant data, ALNY's Price to Sales in the three quarters before Q3 2026 was 8.38 (Q2 2026), 10.30 (Q1 2026) and 14.18 (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Alnylam Pharmaceuticals | 20.30 Bn | 7.49 Bn | 1.10 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 6.59 |
| Jun 30, 2026 | 8.38 |
| Mar 31, 2026 | 10.30 |
| Dec 31, 2025 | 14.18 |
| Sep 30, 2025 | 19.28 |
| Jun 30, 2025 | 16.90 |
| Dec 31, 2024 | 13.53 |
| Sep 30, 2024 | 16.92 |
| Jun 30, 2024 | 13.27 |
| Mar 31, 2024 | 9.43 |
| Dec 31, 2023 | 13.17 |
| Sep 30, 2023 | 12.89 |
| Jun 30, 2023 | 19.17 |
| Mar 31, 2023 | 21.77 |
| Dec 31, 2022 | 28.39 |
| Sep 30, 2022 | 25.62 |
| Jun 30, 2022 | 19.96 |
| Mar 31, 2022 | 22.40 |
| Dec 31, 2021 | 24.14 |
| Sep 30, 2021 | 30.11 |
API Access
Alnylam Pharmaceuticals Price to Sales API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=price-to-sales&ticker=ALNY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "price-to-sales", "ticker": "ALNY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=price-to-sales&ticker=ALNY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();